Adjunctive DAPT Labelling for DES - an FDA View - Andrew Farb, MD

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - Evaluating DES for High-risk DAPT Patients

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Adjunctive DAPT Labelling for DES - an FDA View presented by Andrew Farb, MD at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Clinical Trial Investigators
  • Interventional Fellows
  • Medical Device Professionals


Session Name: Evaluating DES for High-risk DAPT Patients

Track: Technology & Innovation

Learning Objectives

  • Updates in the latest Cardiovascular Innovations

Other Components in this Moment

Overview
Adjunctive DAPT Labelling for DES - an FDA View - Andrew Farb, MD
Can We Define High-risk DAPT Patients in USA Practice? - Roxana Mehran, MD, FACC, FSCAI
The Long and Short of DAPT – an Industry View - Craig Thompson, MD, FSCAI
Loading Simple Education